...
首页> 外文期刊>Psychiatry Investigation >Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis
【24h】

Distinct Inflammation Biomarkers in Healthy Individuals and Patients with Schizophrenia: A Reliability Testing of Multiplex Cytokine Immunoassay by Bland-Altman Analysis

机译:健康个体和精神分裂症患者中不同的炎症生物标记物:通过Bland-Altman分析进行多重细胞因子免疫测定的可靠性测试

获取原文

摘要

Objective Since the inflammatory process has been implicated in the pathophysiology of psychiatric disorder, an important issue emerging is to assess the test-retest reliability of cytokine measurement in healthy individuals and patients with schizophrenia. The objective of the present study was to investigate the test-retest reliability of bead-based multiplex immunoassay technology (BMIT) for cytokine measurement by using a Bland-Altman plot (BAP). Methods Twenty healthy individuals and twenty patients with schizophrenia were enrolled, and a 17-plex cytokine assay was used to measure inflammatory biomarkers at baseline and two weeks later. The test-retest reliability was examined by BAP, 95% limits of agreement (LOA), intraclass correlation coefficient (ICC), and coefficient of repeatability (CoR). Results In the healthy controls, only interleukin (IL)-2, IL-13, IL-10, IL-17, and macrophage inflammatory protein-1β showed excellent ICC. The BAP with 95% LOA determined that 13 cytokines showed acceptable 95% LOA for a 2-week test-retest reliability, and only IL-1β, IL-12 and tumor necrosis factor (TNF)-α had significant test-retest bias. The CoR of cytokines varied significantly, ranging from 1.72 to 218.1. Compared with healthy controls, patients with schizophrenia showed significantly higher levels of IL-5, IL-13, and TNF-α and significantly lower levels of IL-4, IL-12, and interferon-gamma (IFN-γ). Of these six cytokines, IL-12 and TNF-α were considered suboptimal reliability. Conclusion The findings from ICC and CoR implied that the test-retest reliability of BMIT for cytokine measurement were suboptimal. However, the BAP with 95% LOA confirmed that BMIT can reliably distinguish schizophrenia from healthy individuals in cytokine measurement, while significant within-subject variation and between-group overlapping were evident in cytokine expression.
机译:目的由于炎症过程与精神病的病理生理有关,因此评估健康个体和精神分裂症患者细胞因子检测的重测信度是一个重要的问题。本研究的目的是通过使用Bland-Altman图(BAP)研究基于珠的多重免疫测定技术(BMIT)用于细胞因子测量的重测信度。方法招募20名健康人和20名精神分裂症患者,并在基线和两周后使用17-plex细胞因子测定法测定炎性生物标志物。通过BAP,95%的同意限(LOA),组内相关系数(ICC)和重复性系数(CoR)来检查重测可靠性。结果在健康对照组中,只有白介素(IL)-2,IL-13,IL-10,IL-17和巨噬细胞炎性蛋白1β表现出优异的ICC。具有95%LOA的BAP确定13种细胞因子显示可接受的95%LOA,可进行2周的重新测试可靠性,并且只有IL-1β,IL-12和肿瘤坏死因子(TNF)-α具有显着的重新测试偏倚。细胞因子的CoR显着变化,范围从1.72到218.1。与健康对照组相比,精神分裂症患者的IL-5,IL-13和TNF-α水平明显升高,而IL-4,IL-12和干扰素-γ(IFN-γ)水平则明显降低。在这六种细胞因子中,IL-12和TNF-α被认为不是最佳可靠性。结论ICC和CoR的结果表明BMIT在细胞因子测量中的重测信度不是最佳的。然而,具有95%LOA的BAP证实BMIT在细胞因子测量中可以可靠地将精神分裂症与健康个体区分开,而在细胞因子表达中明显的受试者内部变异和组间重叠则很明显。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号